H89 treatment significantly increased the AAA size compared with vehicle treatment (Figure 7, A–C), and elastin fragmentation in the aortic wall was more severe in the H89 group compared with the vehicle group (Figure 7D). The gene discussed is ELN; the disease is triple-A syndrome.